How It Works Science Our Mission Team Join Waitlist
AI-Powered Dermatology  ·  Dermi Labs

Skin health for every skin.

Clinical-grade skin cancer detection powered by AI, built for accuracy and designed for equity across all skin tones.

Join the Waitlist See how it works
26%
Reduction in false negatives
200+
Models trained and evaluated
FST I–VI
Full skin tone coverage
scroll

Detection in three steps.

No dermatologist appointment required. Dermi puts clinical-grade screening in your pocket, fast, private, and accurate.

01

Capture Your Lesion

Use your smartphone camera or pair with our low-cost clip-on dermoscope for high-resolution imaging of suspicious moles or spots.

02

AI Analysis

Our fairness-validated deep learning model analyzes your image in seconds, checking for visual markers of melanoma and other skin cancers with clinical precision.

03

Receive Your Report

Get a plain-language risk assessment with a confidence score, visual explanation, and clear next steps including when to seek professional care.

A clinical tool that fits in your pocket.

Dermi pairs with a low-cost hardware attachment to turn any smartphone into a medical-grade dermoscope. No clinic. No referral. No waiting weeks for an appointment.

Smartphone compatible
Low-cost hardware
Works offline
DERMI AI v2.1 RISK ASSESSMENT Low Risk 21% Consistent with benign seborrheic keratosis. Monitor for changes. View Full Report

Built on rigorous ML research.

Dermi's model is trained and validated on the Fitzpatrick17k dataset with novel fairness metrics, including the WCUG (Worst-Case Underdiagnosis Gap), to ensure no skin tone is left behind.

Fairness-validated AI WCUG metric Fitzpatrick17k Bias detection Influence attribution CNN architecture
Sensitivity — Darker Skin Tones (FST IV–VI)
95%
Reduction in False Negative Rate
26%
Overall Model Accuracy
88%
Statistical Significance
p=.012

Skin cancer doesn't discriminate.
Neither should detection.

The dermatology AI field has a bias problem. We are here to fix it, one model and one skin tone at a time.

3x

Higher Mortality

Black patients are up to three times more likely to die from melanoma than white patients, often because AI diagnostic tools were never built to see them and specialist access remains deeply unequal.

$0

Zero Cost to Screen

Dermi is designed to be free for end users. Combined with a low-cost clip-on dermoscope, anyone with a smartphone can access clinical-grade screening, not just those with insurance or nearby specialists.

This is an AI safety issue. It is also a civil rights issue.

Dermi Labs was built on the belief that equitable healthcare is a human right. Every model we ship is tested against our proprietary fairness framework before it ever reaches a user, because getting it wrong costs lives.

Join the Mission

Built by researchers,
driven by purpose.

Dermi Labs brings together machine learning researchers, medical advisors, and engineers united by one mission: fair AI for every skin tone.

Founder and CEO

Angie Xiu

ML researcher and entrepreneur. Passionate about building AI that saves lives equitably.

M

Medical Advisor

Clinical Dermatology

Board-certified dermatologist providing clinical validation and medical oversight for Dermi's diagnostic models.

R

AI Research Lead

Machine Learning

Specializing in bias detection and fairness-aware ML. Architect of the WCUG fairness validation framework.

Be first. Make a difference.

Dermi is launching soon. Join the waitlist to get early access to the app and hardware, and help us build the most equitable skin cancer detection tool ever made.

Free premium access at launch
Early hardware pricing
Exclusive research updates
Direct line to the founding team

Let's build the future of fair dermatology.

Whether you're a clinician, researcher, investor, or patient advocate, we would love to connect.